Skip to content

BIOSCIENCE NEUTRACEUTICALS, INC.: 10-Q filed 2019-08-12

What BIOSCIENCE NEUTRACEUTICALS, INC. reported in its quarterly report filed 2019-08-12 (fiscal Q2 2019): 22 published measures, 56 facts as tagged in accession 0001640334-19-001591.

This filing

Form
10-Q (quarterly report)
Filed
2019-08-12
Fiscal period
fiscal Q2 2019
Accession
0001640334-19-001591 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIOSCIENCE NEUTRACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-12-316,000USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-06-30217,819USD
At 2018-12-31191,320USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-06-30-217,819USD
At 2019-03-31-202,505USD
At 2018-12-31-185,320USD
At 2018-06-30-168,294USD
At 2018-03-31-141,676USD
At 2017-12-31-129,544USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-06-303,744USD
At 2017-12-311,488USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-15,314USD91
2019-01-01 to 2019-06-30-462,411USD181
2018-04-01 to 2018-06-30-26,618USD91
2018-01-01 to 2018-06-30-38,750USD181
2018-01-01 to 2018-03-31-12,132USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-28,613USD181
2018-01-01 to 2018-06-30-30,370USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-06-3028,613USD181
2018-01-01 to 2018-06-3032,626USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-06-30-780,678USD
At 2018-12-31-318,267USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-04-01 to 2019-06-308,042,516shares91
2019-01-01 to 2019-06-304,648,011shares181
2018-04-01 to 2018-06-309,680,435shares91
2018-01-01 to 2018-06-30242,500shares181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-06-30421,912USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-10,090USD91
2019-01-01 to 2019-06-30-451,009USD181
2018-04-01 to 2018-06-30-18,519USD91
2018-01-01 to 2018-06-30-20,007USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-12-316,000USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-01-01 to 2019-06-306,573USD181
2018-01-01 to 2018-06-306,017USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-06-30213,862USD
At 2018-12-31187,363USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-04-01 to 2019-06-3010,090USD91
2019-01-01 to 2019-06-30451,009USD181
2018-04-01 to 2018-06-3018,519USD91
2018-01-01 to 2018-06-3020,007USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-06-308,042,516shares
At 2018-12-31242,516shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-06-30562,055USD
At 2018-12-31132,923USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-06-3041,149USD
At 2018-12-3129,747USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-15,314USD91
2019-01-01 to 2019-06-30-462,411USD181
2018-04-01 to 2018-06-30-24,882USD91
2018-01-01 to 2018-06-30-32,102USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-01-01 to 2019-06-30382USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-5,224USD91
2019-01-01 to 2019-06-30-11,402USD181
2018-04-01 to 2018-06-30-6,363USD91
2018-01-01 to 2018-06-30-12,095USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-06-30-1,715USD181

Inspect the source

Entity
BIOSCIENCE NEUTRACEUTICALS, INC. / CIK 0001555995
Captured
SEC response SHA-256
c921d1752ffe8707c5ec53cec673b137833be5f128a53b9c1fb5c3a6f4805760

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001555995.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))